Market Research Logo

Global Autoimmune Drugs Market 2018-2022

Global Autoimmune Drugs Market 2018-2022

About this market

High cost of autoimmune drugs to drive market growth. Governments and regulatory bodies have undertaken several initiatives to reduce the costs of therapies for autoimmune disorders mainly rheumatoid arthritis. Despite these efforts, autoimmune drugs continue to remain expensive. Biologics and biosimilars are expensive when compared with conventional therapies such as NSAIDs. Technavio’ s analysts have predicted that the autoimmune drugs market will register a CAGR of more than 8% by 2022.

Market Overview

Targeted therapeutic mechanism of biologics

By providing a targeted action, biologics tend to be more effective and have lesser side effects compared with small molecule agents. Hence, the introduction of biologic therapy to manage autoimmune disorders is driving the market at a very rapid pace.

Reimbursement challenges of autoimmune drugs

The insurers are reluctant to provide reimbursement for the drugs for treatment of autoimmune diseases due to the lack of knowledge; therefore, they generally do not provide any provisions for the reimbursement of drugs for rheumatoid arthritis and other autoimmune diseases.

For the detailed list of factors that will drive and challenge the growth of the autoimmune drugs market during the 2018-2022, view our report.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies including Techman-Head Group and Brackett Aircraft Company the competitive environment is quite intense. Factors such as the targeted therapeutic mechanism of biologics and the high cost of autoimmune drugs, will provide considerable growth opportunities to autoimmune drugs manufactures. AbbVie, Amgen, Johnson & Johnson, Novartis, Pfizer, and UCB are some of the major companies covered in this report.


PRESS RELEASE

Technavio Announces the Publication of its Research Report – Global Autoimmune Drugs Market 2018-2022

Technavio recognizes the following companies as the key players in the global autoimmune drugs market: AbbVie, Amgen, Johnson & Johnson, Novartis, Pfizer, and UCB.

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is the high cost of autoimmune drugs.”

According to the report, one of the major drivers for this market is the targeted therapeutic mechanism of biologics.

Companies Mentioned

AbbVie

Amgen

Johnson & Johnson

Novartis

Pfizer

and UCB

  • Executive summary
  • Scope of the report
  • Research methodology
  • Market landscape
    • Market ecosystem
      • Table Parent market
      • Table Global pharmaceuticals market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Pipeline analysis
    • Table mAbs and biologics for autoimmune diseases
    • Table Small molecules for autoimmune diseases
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2017
      • Table Market size 2017
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast 2017-2022
      • Table Global – Market size and forecast 2017-2022 ($ bn)
      • Table Biosimilars approved in 2017
      • Table Global – Year-over-year growth 2018-2022 (%)
  • Five forces analysis
    • Table Five forces analysis 2017
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2017
  • Market segmentation by therapy area
    • Segmentation by therapy area
      • Table Therapy area – Market share 2017-2022 (%)
    • Comparison by therapy area
      • Table Comparison by therapy area
    • Rheumatoid arthritis – Market size and forecast 2017-2022
      • Table Rheumatoid arthritis – Market size and forecast 2017-2022 ($ bn)
      • Table Rheumatoid arthritis – Year-over-year growth 2018-2022 (%)
    • Multiple sclerosis – Market size and forecast 2017-2022
      • Table Multiple sclerosis – Market size and forecast 2017-2022 ($ bn)
      • Table Multiple sclerosis – Year-over-year growth 2018-2022 (%)
    • Psoriasis – Market size and forecast 2017-2022
      • Table Psoriasis – Market size and forecast 2017-2022 ($ bn)
      • Table Psoriasis – Year over year growth 2018-2022 (%)
    • Inflammatory bowel disease – Market size and forecast 2017-2022
      • Table Inflammatory bowel disease – Market size and forecast 2017-2022 ($ bn)
      • Table Inflammatory bowel disease – Year-over-year growth 2018-2022 (%)
    • Others – Market size and forecast 2017-2022
      • Table Others – Market size and forecast 2017-2022 ($ bn)
      • Table Others – Year-over-year growth 2018-2022 (%)
    • Market opportunity by therapy area
      • Table Market opportunity by therapy area
  • Market segmentation by type of molecule
    • Segmentation by type of molecule
    • Biologics
    • Small molecules
  • Customer landscape
    • Table Customer landscape
  • Regional landscape
    • Geographical segmentation
      • Table Global – Market share by geography 2017-2022 (%)
    • Regional comparison
      • Table Regional comparison
    • Americas – Market size and forecast 2017-2022
      • Table Americas – Market size and forecast 2017-2022 ($ bn)
      • Table Molecules in the pipeline for autoimmune disorders in the Americas
      • Table Americas – Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in Americas
    • EMEA – Market size and forecast 2017-2022
      • Table EMEA – Market size and forecast 2017-2022 ($ bn)
      • Table EMEA – Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in EMEA
    • APAC – Market size and forecast 2017-2022
      • Table APAC – Market size and forecast 2017-2022 ($ bn)
      • Table APAC – Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in APAC
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
  • Market trends
    • Table Sales of major autoimmune drugs
    • Table Patent expiration dates for some of the biologics
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • AbbVie
      • Table AbbVie overview
      • Table AbbVie – Business segments
      • Table AbbVie – Organizational developments
      • Table AbbVie – Geographic focus
      • Table AbbVie – Key offerings
    • Amgen
      • Table Amgen overview
      • Table Amgen – Business segments
      • Table Amgen – Organizational developments
      • Table Amgen – Geographic focus
      • Table Amgen – Key offerings
    • Johnson & Johnson
      • Table Johnson & Johnson overview
      • Table Johnson & Johnson – Business segments
      • Table Johnson & Johnson – Organizational developments
      • Table Johnson & Johnson – Geographic focus
      • Table Johnson & Johnson – Segment focus
      • Table Johnson & Johnson – Key offerings
    • Novartis
      • Table Novartis overview
      • Table Novartis – Business segments
      • Table Novartis – Organizational developments
      • Table Novartis – Geographic focus
      • Table Novartis – Segment focus
      • Table Novartis – Key offerings
    • Pfizer
      • Table Pfizer overview
      • Table Pfizer – Business segments
      • Table Pfizer – Organizational developments
      • Table Pfizer – Geographic focus
      • Table Pfizer – Segment focus
      • Table Pfizer – Key offerings
    • UCB
      • Table UCB overview
      • Table UCB – Business segments
      • Table UCB – Organizational developments
      • Table UCB – Geographic focus
      • Table UCB – Segment focus
      • Table UCB – Key offerings
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report